Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1822788Generated: November 2, 2026

1,8-Diazabicyclo(5.4.0)undec-7-ene → 2-Chloro-4-propyl-6-[4-(3-trifluoromethoxyphenyl)-imidazol-1-yl]-pyrimidine

https://huagongshe.com/reaction/1822788

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1,8-Diazabicyclo(5.4.0)undec-7-eneHCID 81184—
Reactant2,4-Dichloro-6-propylpyrimidineHCID 246011—
ReactantHCID 178506377HCID 178506377—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
Product4-Chloro-6-propyl-2-[4-(3-trifluoromethoxyphenyl)-imidazol-1-yl]-pyrimidineHCID 22170026—
Product2-Chloro-4-propyl-6-[4-(3-trifluoromethoxyphenyl)-imidazol-1-yl]-pyrimidineHCID 2217003958.8%

Reaction Steps

To a solution of 2,4-dichloro-6-propyl-pyrimidine (0.15 g) and 4-(3-trifluoromethoxy-phenyl)-1H-imidazole (0.2 g) in N,N-dimethylformamide (10 mL) was added 1,8-diazabicyclo[5.4.0]undec-7-ene (0.18 mL). After stirring at room temperature overnight, the solution was taken up in water and extracted three times with ethyl acetate. The ethyl acetate layers were combined washed twice with brine, dried over magnesium sulfate, and the volatiles were removed in vacuo. The resulting oil was purified on silica gel using 20% ethyl acetate/hexanes as the mobile phase to yield 4-chloro-6-propyl-2-[4-(3-trifluoromethoxyphenyl)-imidazol-1-yl]-pyrimidine (72.5 mg, first eluting regioisomer, ESI-MS (m/z) 383.3/385.2 [M+H]+, and 2-chloro-4-propyl-6-[4-(3-trifluoromethoxyphenyl)-imidazol-1-yl]-pyrimidine (88.4 mg, second eluting regioisomer).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07037916B2
Source datasetuspto-grants-2006_05
ORD IDord-f0e1ed45bded44c08fdb96d7581fff3d
Source noteuspto-grants-2006_05